These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32885363)

  • 1. Cancer stem cells and ceramide signaling: the cutting edges of immunotherapy.
    Ghosh S; Juin SK; Majumdar S
    Mol Biol Rep; 2020 Oct; 47(10):8101-8111. PubMed ID: 32885363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cells: Regulation programs, immunological properties and immunotherapy.
    Zhang D; Tang DG; Rycaj K
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):94-106. PubMed ID: 29752993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
    Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L
    Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic Targeting of Cancer Stem Cells.
    Zhang J; Li Q; Chang AE
    Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology of cancer stem cells in solid tumours. A review.
    Maccalli C; Volontè A; Cimminiello C; Parmiani G
    Eur J Cancer; 2014 Feb; 50(3):649-55. PubMed ID: 24333096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
    Plaks V; Kong N; Werb Z
    Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
    Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
    Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells and angiogenesis.
    Zhao Y; Bao Q; Renner A; Camaj P; Eichhorn M; Ischenko I; Angele M; Kleespies A; Jauch KW; Bruns C
    Int J Dev Biol; 2011; 55(4-5):477-82. PubMed ID: 21732274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of cancer-stem cell antigens and development of CTL-mediated cancer immunotherapy].
    Miyamoto S; Kanaseki T; Hirohashi Y; Tsukahara T; Kikuchi Y; Sato N; Torigoe T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):40-47. PubMed ID: 28539553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Cancer Stem Cell Targeted Therapy.
    Akbulut H; Babahan C; Abgarmi SA; Ocal M; Besler M
    Crit Rev Oncog; 2019; 24(1):1-20. PubMed ID: 31679215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties.
    Mahmoodi S; Nezafat N; Negahdaripour M; Ghasemi Y
    Curr Mol Med; 2019; 19(1):2-11. PubMed ID: 30714514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.
    Luna JI; Grossenbacher SK; Murphy WJ; Canter RJ
    Expert Opin Biol Ther; 2017 Mar; 17(3):313-324. PubMed ID: 27960589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
    Kozlowska AK; Kaur K; Topchyan P; Jewett A
    Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cancer stem cells in the modulation of anti-tumor immune responses.
    Maccalli C; Rasul KI; Elawad M; Ferrone S
    Semin Cancer Biol; 2018 Dec; 53():189-200. PubMed ID: 30261276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crucial role of glucosylceramide synthase in the regulation of stem cell-like cancer cells in B16F10 murine melanoma.
    Ghosh S; Juin SK; Bhattacharyya Majumdar S; Majumdar S
    Mol Carcinog; 2021 Dec; 60(12):840-858. PubMed ID: 34516706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.
    Gammaitoni L; Leuci V; Mesiano G; Giraudo L; Todorovic M; Carnevale-Schianca F; Aglietta M; Sangiolo D
    Expert Opin Biol Ther; 2014 Sep; 14(9):1259-70. PubMed ID: 24835841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.